Alcoholic Hepatitis Treatment Market
Alcoholic Hepatitis Treatment Market: Global Industry Analysis 2012-2022 and Opportunity Assessment 2023-2033
A recent market study published by FMI on Alcoholic Hepatitis Treatment offers a global industry analysis for 2012-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Treatment:
- Drug Treatment
- Acamprosate
- Naltrexone
- Pentoxifylline
- Infliximab
- Corticosteroids
- Benzodiazepines
- Nutritional Supplements
- Others
- Stem Cell Therapy
- Oral
- Injectable
- Institutional Sales
- Hospitals
- Stem Cell Centers
- Specialized Clinics
- Cancer Research Institutes
- Retail Sales
- Retail Pharmacies
- E- Commerce/Mail Order Pharmacies
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Executive Summary
The executive summary of the Alcoholic Hepatitis Treatment Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Alcoholic Hepatitis Treatment Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Alcoholic Hepatitis Treatment Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Treatment processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Alcoholic Hepatitis Treatment Market Demand Analysis 2012-2022 and Forecast, 2023-2033
The chapter include historical market value (US$ 2.6 Billion) analysis (2012-2022) and current and future market value (US$ 2.8 Billion) and volume (6.5%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Alcoholic Hepatitis Treatment Market - Pricing Analysis
Based on By Treatment, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033, By Treatment
Based on By Treatment, Alcoholic Hepatitis Treatment Market is segmented into Drug Treatment (Acamprosate, Naltrexone, Pentoxifylline, Infliximab, Corticosteroids, Benzodiazepines, Nutritional Supplements, Others), Stem Cell Therapy. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Treatment.
Chapter 06 - Global Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033, By Route of Administration
Based on By Route of Administration, Alcoholic Hepatitis Treatment Market is segmented into Oral, Injectable. This section also offers market attractiveness analysis based on By Route of Administration. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Route of Administration.
Chapter 07 - Global Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033, By Distribution Channel
Based on By Distribution Channel, Alcoholic Hepatitis Treatment Market is segmented into Institutional Sales (Hospitals, Stem Cell Centers, Specialized Clinics, Cancer Research Institutes), Retail Sales (Retail Pharmacies, E- Commerce/Mail Order Pharmacies). This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.
Chapter 08 - Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033, By Region
Based on By Region, Alcoholic Hepatitis Treatment Market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA). This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 09 - North America Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 10 - Latin America Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the Latin America region.
Chapter 11 - Europe Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the regional market.
Chapter 12 - East Asia Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the regional market.
Chapter 13 - South Asia Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the regional market.
Chapter 14 - Middle East and Africa Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the regional market.
Chapter 15 - Key Countries Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033
This chapter offers insights into how the Alcoholic Hepatitis Treatment Market is expected to grow in major countries globally.
Chapter 16 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 17 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Treatment portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are F. Hoffmann-La Roche Ltd (Genentech, Inc), Teva Pharmaceuticals, Pfizer, Alkermes, Inc, Viatris Inc, Merck KGaA, Sun Pharmaceutical Industries Ltd, Hikma Pharmaceuticals PLC, H. Lundbeck A/S, Mallinckrodt, Glenmark Pharmaceuticals U.S. Inc, Torrent Pharmaceuticals Ltd, Wellona Pharma.
Chapter 18 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.
Chapter 19 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Alcoholic Hepatitis Treatment Market.
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions and Exclusions
- 3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 4. Value-Added Insights
- 4.1. Product Adoption / Usage Analysis
- 4.2. Disease spectrum
- 4.3. Algorithm For The Evaluation And Management of Patients with Alcoholic Liver Disease
- 4.4. Therapeutic Algorithm Of Alcoholic Liver Disease
- 4.5. Regulatory Scenario
- 4.6. PESTLE Analysis
- 4.7. Porter’s Analysis
- 4.8. Key Promotional Strategies, by Key Manufacturers
- 5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Top Companies Historical Growth
- 5.2.2. Increasing Prevalence of Chronic Liver Diseases
- 5.2.3. Treatment Seeking Rate
- 5.2.4. Key Strategic Developments
- 5.2.5. Increasing Investment in R&D Activities
- 5.2.6. Cost of Drugs
- 5.2.7. Regulatory Dynamics
- 5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
- 6. COVID-19 Crisis Analysis
- 6.1. COVID-19 and Impact Analysis
- 6.1.1. Revenue By Treatment
- 6.1.2. Revenue By Route of Administration
- 6.1.3. Revenue By Distribution Channel
- 6.1.4. Revenue By Country
- 6.2. 2022 Market Scenario
- 7. Global Market Demand Value or Size (US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033
- 7.1. Historical Market Value (US$ Million) Trend Analysis, 2013 to 2023
- 7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
- 8. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Treatment
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Million) Analysis By Treatment, 2012 to 2022
- 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033
- 8.3.1. Drug Treatment
- 8.3.1.1. Acamprosate
- 8.3.1.2. Naltrexone
- 8.3.1.3. Pentoxifylline
- 8.3.1.4. Infliximab
- 8.3.1.5. Corticosteroids
- 8.3.1.6. Benzodiazepines
- 8.3.1.7. Nutritional Supplements
- 8.3.1.8. Others
- 8.3.2. Stem Cell Therapy
- 8.4. Market Attractiveness Analysis By Treatment
- 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Route of Administration
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Million), By Route of Administration, 2012 to 2022
- 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033
- 9.3.1. Oral
- 9.3.2. Injectable
- 9.4. Market Attractiveness Analysis By Route of Administration
- 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Million), By Distribution Channel, 2012 to 2022
- 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
- 10.3.1. Institutional Sales
- 10.3.1.1. Hospitals
- 10.3.1.2. Stem Cell Centers
- 10.3.1.3. Specialized Clinics
- 10.3.1.4. Cancer Research Institutes
- 10.3.2. Retail Sales
- 10.3.2.1. Retail Pharmacies
- 10.3.2.2. E-Commerce/Mail Order Pharmacies
- 10.4. Market Attractiveness Analysis By Distribution Channel
- 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2022
- 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. East Asia
- 11.3.5. South Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa (MEA)
- 11.4. Market Attractiveness Analysis By Region
- 12. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
- 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
- 12.3.1. By Country
- 12.3.1.1. USA
- 12.3.1.2. Canada
- 12.3.2. By Treatment
- 12.3.3. By Route of Administration
- 12.3.4. By Distribution Channel
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Treatment
- 12.4.3. By Route of Administration
- 12.4.4. By Distribution Channel
- 12.5. Market Trends
- 12.6. Key Market Participants - Intensity Mapping
- 12.7. Drivers and Restraints - Impact Analysis
- 12.8. Country-Level Analysis & Forecast
- 12.8.1. USA Market Analysis
- 12.8.1.1. Introduction
- 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 12.8.1.2.1. By Treatment
- 12.8.1.2.2. By Route of Administration
- 12.8.1.2.3. By Distribution Channel
- 12.8.2. Canada Market Analysis
- 12.8.2.1. Introduction
- 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 12.8.2.2.1. By Treatment
- 12.8.2.2.2. By Route of Administration
- 12.8.2.2.3. By Distribution Channel
- 13. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
- 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
- 13.3.1. By Country
- 13.3.1.1. Mexico
- 13.3.1.2. Brazil
- 13.3.1.3. Argentina
- 13.3.1.4. Rest of Latin America
- 13.3.2. By Treatment
- 13.3.3. By Route of Administration
- 13.3.4. By Distribution Channel
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Treatment
- 13.4.3. By Route of Administration
- 13.4.4. By Distribution Channel
- 13.5. Market Trends
- 13.6. Key Market Participants - Intensity Mapping
- 13.7. Drivers and Restraints - Impact Analysis
- 13.8. Country-Level Analysis & Forecast
- 13.8.1. Mexico Market Analysis
- 13.8.1.1. Introduction
- 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.1.2.1. By Treatment
- 13.8.1.2.2. By Route of Administration
- 13.8.1.2.3. By Distribution Channel
- 13.8.2. Brazil Market Analysis
- 13.8.2.1. Introduction
- 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.2.2.1. By Treatment
- 13.8.2.2.2. By Route of Administration
- 13.8.2.2.3. By Distribution Channel
- 13.8.3. Argentina Market Analysis
- 13.8.3.1. Introduction
- 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.3.2.1. By Treatment
- 13.8.3.2.2. By Route of Administration
- 13.8.3.2.3. By Distribution Channel
- 14. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
- 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
- 14.3.1. By Country
- 14.3.1.1. Germany
- 14.3.1.2. Italy
- 14.3.1.3. France
- 14.3.1.4. United Kingdom
- 14.3.1.5. Spain
- 14.3.1.6. BENELUX
- 14.3.1.7. Russia
- 14.3.1.8. Rest of Europe
- 14.3.2. By Treatment
- 14.3.3. By Route of Administration
- 14.3.4. By Distribution Channel
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Treatment
- 14.4.3. By Route of Administration
- 14.4.4. By Distribution Channel
- 14.5. Market Trends
- 14.6. Key Market Participants - Intensity Mapping
- 14.7. Drivers and Restraints - Impact Analysis
- 14.8. Country-Level Analysis & Forecast
- 14.8.1. Germany Market Analysis
- 14.8.1.1. Introduction
- 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.1.2.1. By Treatment
- 14.8.1.2.2. By Route of Administration
- 14.8.1.2.3. By Distribution Channel
- 14.8.2. Italy Market Analysis
- 14.8.2.1. Introduction
- 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.2.2.1. By Treatment
- 14.8.2.2.2. By Route of Administration
- 14.8.2.2.3. By Distribution Channel
- 14.8.3. France Market Analysis
- 14.8.3.1. Introduction
- 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.3.2.1. By Treatment
- 14.8.3.2.2. By Route of Administration
- 14.8.3.2.3. By Distribution Channel
- 14.8.4. United Kingdom Market Analysis
- 14.8.4.1. Introduction
- 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.4.2.1. By Treatment
- 14.8.4.2.2. By Route of Administration
- 14.8.4.2.3. By Distribution Channel
- 14.8.5. Spain Market Analysis
- 14.8.5.1. Introduction
- 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.5.2.1. By Treatment
- 14.8.5.2.2. By Route of Administration
- 14.8.5.2.3. By Distribution Channel
- 14.8.6. BENELUX Market Analysis
- 14.8.6.1. Introduction
- 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.6.2.1. By Treatment
- 14.8.6.2.2. By Route of Administration
- 14.8.6.2.3. By Distribution Channel
- 14.8.7. Russia Market Analysis
- 14.8.7.1. Introduction
- 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.7.2.1. By Treatment
- 14.8.7.2.2. By Route of Administration
- 14.8.7.2.3. By Distribution Channel
- 15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
- 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
- 15.3.1. By Country
- 15.3.1.1. India
- 15.3.1.2. Indonesia
- 15.3.1.3. Malaysia
- 15.3.1.4. Thailand
- 15.3.1.5. Rest of South Asia
- 15.3.2. By Treatment
- 15.3.3. By Route of Administration
- 15.3.4. By Distribution Channel
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Treatment
- 15.4.3. By Route of Administration
- 15.4.4. By Distribution Channel
- 15.5. Market Trends
- 15.6. Key Market Participants - Intensity Mapping
- 15.7. Drivers and Restraints - Impact Analysis
- 15.8. Country-Level Analysis & Forecast
- 15.8.1. India Market Analysis
- 15.8.1.1. Introduction
- 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.1.2.1. By Treatment
- 15.8.1.2.2. By Route of Administration
- 15.8.1.2.3. By Distribution Channel
- 15.8.2. Indonesia Market Analysis
- 15.8.2.1. Introduction
- 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.2.2.1. By Treatment
- 15.8.2.2.2. By Route of Administration
- 15.8.2.2.3. By Distribution Channel
- 15.8.3. Malaysia Market Analysis
- 15.8.3.1. Introduction
- 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.3.2.1. By Treatment
- 15.8.3.2.2. By Route of Administration
- 15.8.3.2.3. By Distribution Channel
- 15.8.4. Thailand Market Analysis
- 15.8.4.1. Introduction
- 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.4.2.1. By Treatment
- 15.8.4.2.2. By Route of Administration
- 15.8.4.2.3. By Distribution Channel
- 16. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
- 16.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2023 to 2033
- 16.3.1. By Country
- 16.3.1.1. China
- 16.3.1.2. Japan
- 16.3.1.3. South Korea
- 16.3.2. By Treatment
- 16.3.3. By Route of Administration
- 16.3.4. By Distribution Channel
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Treatment
- 16.4.3. By Route of Administration
- 16.4.4. By Distribution Channel
- 16.5. Market Trends
- 16.6. Key Market Participants - Intensity Mapping
- 16.7. Drivers and Restraints - Impact Analysis
- 16.8. Country-Level Analysis & Forecast
- 16.8.1. China Market Analysis
- 16.8.1.1. Introduction
- 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.1.2.1. By Treatment
- 16.8.1.2.2. By Route of Administration
- 16.8.1.2.3. By Distribution Channel
- 16.8.2. Japan Market Analysis
- 16.8.2.1. Introduction
- 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.2.2.1. By Treatment
- 16.8.2.2.2. By Route of Administration
- 16.8.2.2.3. By Distribution Channel
- 16.8.3. South Korea Market Analysis
- 16.8.3.1. Introduction
- 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.3.2.1. By Treatment
- 16.8.3.2.2. By Route of Administration
- 16.8.3.2.3. By Distribution Channel
- 17. Oceania Market 2012 to 2022 and Forecast 2023 to 2033
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
- 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
- 17.3.1. By Country
- 17.3.1.1. Australia
- 17.3.1.2. New Zealand
- 17.3.2. By Treatment
- 17.3.3. By Route of Administration
- 17.3.4. By Distribution Channel
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Treatment
- 17.4.3. By Route of Administration
- 17.4.4. By Distribution Channel
- 17.5. Market Trends
- 17.6. Key Market Participants - Intensity Mapping
- 17.7. Drivers and Restraints - Impact Analysis
- 17.8. Country-Level Analysis & Forecast
- 17.8.1. Australia Market Analysis
- 17.8.1.1. Introduction
- 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.1.2.1. By Treatment
- 17.8.1.2.2. By Route of Administration
- 17.8.1.2.3. By Distribution Channel
- 17.8.2. New Zealand Market Analysis
- 17.8.2.1. Introduction
- 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.2.2.1. By Treatment
- 17.8.2.2.2. By Route of Administration
- 17.8.2.2.3. By Distribution Channel
- 18. Middle East and Africa (MEA) Market Analysis 2012 to 2022 and Forecast 2023 to 2033
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
- 18.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
- 18.3.1. By Country
- 18.3.1.1. GCC Countries
- 18.3.1.2. Türkiye
- 18.3.1.3. South Africa
- 18.3.1.4. North Africa
- 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Treatment
- 18.3.3. By Route of Administration
- 18.3.4. By Distribution Channel
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Treatment
- 18.4.3. By Route of Administration
- 18.4.4. By Distribution Channel
- 18.5. Market Trends
- 18.6. Key Market Participants - Intensity Mapping
- 18.7. Drivers and Restraints - Impact Analysis
- 18.8. Country-Level Analysis & Forecast
- 18.8.1. GCC Countries Market Analysis
- 18.8.1.1. Introduction
- 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.1.2.1. By Treatment
- 18.8.1.2.2. By Route of Administration
- 18.8.1.2.3. By Distribution Channel
- 18.8.2. Türkiye Market Analysis
- 18.8.2.1. Introduction
- 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.2.2.1. By Treatment
- 18.8.2.2.2. By Route of Administration
- 18.8.2.2.3. By Distribution Channel
- 18.8.3. South Africa Market Analysis
- 18.8.3.1. Introduction
- 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.3.2.1. By Treatment
- 18.8.3.2.2. By Route of Administration
- 18.8.3.2.3. By Distribution Channel
- 18.8.4. North Africa Market Analysis
- 18.8.4.1. Introduction
- 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.4.2.1. By Treatment
- 18.8.4.2.2. By Route of Administration
- 18.8.4.2.3. By Distribution Channel
- 19. Market Structure Analysis
- 19.1. Market Analysis by Tier of Companies
- 19.2. Market Share Analysis of Top Players
- 19.3. Market Presence Analysis
- 19.3.1. Regional Footprint Analysis
- 19.3.2. Channel Footprint Analysis
- 20. Competition Analysis
- 20.1. Competition Dashboard
- 20.2. Competition Benchmarking
- 20.3. Key Development Analysis
- 20.4. Branding and Promotional Strategies
- 20.5. Competition Deep Dive
- 20.5.1. F. Hoffmann-La Roche Ltd (Genentech, Inc)
- 20.5.1.1. Overview
- 20.5.1.2. Product Portfolio
- 20.5.1.3. Key Financial
- 20.5.1.4. Sales Footprint
- 20.5.1.5. Key Developments
- 20.5.1.6. SWOT Analysis
- 20.5.1.7. Strategy Overview
- 20.5.1.7.1. Marketing Strategies
- 20.5.1.7.2. Channel Strategies
- 20.5.2. Teva Pharmaceuticals
- 20.5.2.1. Overview
- 20.5.2.2. Product Portfolio
- 20.5.2.3. Key Financial
- 20.5.2.4. Sales Footprint
- 20.5.2.5. Key Developments
- 20.5.2.6. SWOT Analysis
- 20.5.2.7. Strategy Overview
- 20.5.2.7.1. Marketing Strategies
- 20.5.2.7.2. Channel Strategies
- 20.5.3. Pfizer
- 20.5.3.1. Overview
- 20.5.3.2. Product Portfolio
- 20.5.3.3. Key Financial
- 20.5.3.4. Sales Footprint
- 20.5.3.5. Key Developments
- 20.5.3.6. SWOT Analysis
- 20.5.3.7. Strategy Overview
- 20.5.3.7.1. Marketing Strategies
- 20.5.3.7.2. Channel Strategies
- 20.5.4. Alkermes, Inc
- 20.5.4.1. Overview
- 20.5.4.2. Product Portfolio
- 20.5.4.3. Key Financial
- 20.5.4.4. Sales Footprint
- 20.5.4.5. Key Developments
- 20.5.4.6. SWOT Analysis
- 20.5.4.7. Strategy Overview
- 20.5.4.7.1. Marketing Strategies
- 20.5.4.7.2. Channel Strategies
- 20.5.5. Viatris Inc
- 20.5.5.1. Overview
- 20.5.5.2. Product Portfolio
- 20.5.5.3. Key Financial
- 20.5.5.4. Sales Footprint
- 20.5.5.5. Key Developments
- 20.5.5.6. SWOT Analysis
- 20.5.5.7. Strategy Overview
- 20.5.5.7.1. Marketing Strategies
- 20.5.5.7.2. Channel Strategies
- 20.5.6. Merck KGaA
- 20.5.6.1. Overview
- 20.5.6.2. Product Portfolio
- 20.5.6.3. Key Financial
- 20.5.6.4. Sales Footprint
- 20.5.6.5. Key Developments
- 20.5.6.6. SWOT Analysis
- 20.5.6.7. Strategy Overview
- 20.5.6.7.1. Marketing Strategies
- 20.5.6.7.2. Channel Strategies
- 20.5.7. Sun Pharmaceutical Industries Ltd
- 20.5.7.1. Overview
- 20.5.7.2. Product Portfolio
- 20.5.7.3. Key Financial
- 20.5.7.4. Sales Footprint
- 20.5.7.5. Key Developments
- 20.5.7.6. SWOT Analysis
- 20.5.7.7. Strategy Overview
- 20.5.7.7.1. Marketing Strategies
- 20.5.7.7.2. Channel Strategies
- 20.5.8. Hikma Pharmaceuticals PLC
- 20.5.8.1. Overview
- 20.5.8.2. Product Portfolio
- 20.5.8.3. Key Financial
- 20.5.8.4. Sales Footprint
- 20.5.8.5. Key Developments
- 20.5.8.6. SWOT Analysis
- 20.5.8.7. Strategy Overview
- 20.5.8.7.1. Marketing Strategies
- 20.5.8.7.2. Channel Strategies
- 20.5.9. H. Lundbeck A/S
- 20.5.9.1. Overview
- 20.5.9.2. Product Portfolio
- 20.5.9.3. Key Financial
- 20.5.9.4. Sales Footprint
- 20.5.9.5. Key Developments
- 20.5.9.6. SWOT Analysis
- 20.5.9.7. Strategy Overview
- 20.5.9.7.1. Marketing Strategies
- 20.5.9.7.2. Channel Strategies
- 20.5.10. Mallinckrodt
- 20.5.10.1. Overview
- 20.5.10.2. Product Portfolio
- 20.5.10.3. Key Financial
- 20.5.10.4. Sales Footprint
- 20.5.10.5. Key Developments
- 20.5.10.6. SWOT Analysis
- 20.5.10.7. Strategy Overview
- 20.5.10.7.1. Marketing Strategies
- 20.5.10.7.2. Channel Strategies
- 20.5.11. Glenmark Pharmaceuticals USA Inc
- 20.5.11.1. Overview
- 20.5.11.2. Product Portfolio
- 20.5.11.3. Key Financial
- 20.5.11.4. Sales Footprint
- 20.5.11.5. Key Developments
- 20.5.11.6. SWOT Analysis
- 20.5.11.7. Strategy Overview
- 20.5.11.7.1. Marketing Strategies
- 20.5.11.7.2. Channel Strategies
- 20.5.12. Torrent Pharmaceuticals Ltd
- 20.5.12.1. Overview
- 20.5.12.2. Product Portfolio
- 20.5.12.3. Key Financial
- 20.5.12.4. Sales Footprint
- 20.5.12.5. Key Developments
- 20.5.12.6. SWOT Analysis
- 20.5.12.7. Strategy Overview
- 20.5.12.7.1. Marketing Strategies
- 20.5.12.7.2. Channel Strategies
- 20.5.13. Wellona Pharma
- 20.5.13.1. Overview
- 20.5.13.2. Product Portfolio
- 20.5.13.3. Key Financial
- 20.5.13.4. Sales Footprint
- 20.5.13.5. Key Developments
- 20.5.13.6. SWOT Analysis
- 20.5.13.7. Strategy Overview
- 20.5.13.7.1. Marketing Strategies
- 20.5.13.7.2. Channel Strategies
- 21. Assumptions and Acronyms Used
- 22. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook